<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="extensive surface area for these interactions. A remarkable decrease in" exact="viral" post="infectivity was demonstrated by increased cell viability results after"/>
 <result pre="viruses compared to 33.9% cell viability with non-treated viruses. Intracellular" exact="viral" post="RNA quantification by real-time RT-PCR also confirmed that PoGNP"/>
 <result pre="quantification by real-time RT-PCR also confirmed that PoGNP successfully inhibited" exact="viral" post="membrane fusion by blocking the viral entry process through"/>
 <result pre="that PoGNP successfully inhibited viral membrane fusion by blocking the" exact="viral" post="entry process through conformational deformation of HA. Conclusion We"/>
 <result pre="antiviral protection as well as metal nanoparticle-based therapy to treat" exact="viral infection." post="Additionally, facile detection of IAV can be achieved by"/>
 <result pre="Disulfide bond Funding http://dx.doi.org/10.13039/501100003725National Research Foundation of Korea 2018M3A9H4056340HaamSeungjoo Introduction" exact="Acute" post="respiratory diseases comprise over 75% of overall infectious disease"/>
 <result pre="bond Funding http://dx.doi.org/10.13039/501100003725National Research Foundation of Korea 2018M3A9H4056340HaamSeungjoo Introduction Acute" exact="respiratory" post="diseases comprise over 75% of overall infectious disease occurrences"/>
 <result pre="2018M3A9H4056340HaamSeungjoo Introduction Acute respiratory diseases comprise over 75% of overall" exact="infectious disease" post="occurrences in developed countries, of which 80% are caused"/>
 <result pre="Introduction Acute respiratory diseases comprise over 75% of overall infectious" exact="disease" post="occurrences in developed countries, of which 80% are caused"/>
 <result pre="blocked by the M2 ion channel inhibitor, which results in" exact="incomplete" post="viral uncoating and prevents viral replication. The NA inhibitor"/>
 <result pre="by the M2 ion channel inhibitor, which results in incomplete" exact="viral" post="uncoating and prevents viral replication. The NA inhibitor interrupts"/>
 <result pre="channel inhibitor, which results in incomplete viral uncoating and prevents" exact="viral" post="replication. The NA inhibitor interrupts the hydrolysis of terminal"/>
 <result pre="of viruses from the infected host cell. Promotion of IV" exact="infection" post="is interrupted with these inhibitors. However, the U.S. Centers"/>
 <result pre="is interrupted with these inhibitors. However, the U.S. Centers for" exact="Disease" post="Control (CDC) announced that over 99% of IV strains"/>
 <result pre="the commercialized NA inhibitor, Tamiflu (oseltamivir) [5, 6]. Mutation of" exact="viral" post="surface proteins has triggered incremental IV resistance to conventional"/>
 <result pre="transforming the drug binding site in its protein, hence increasing" exact="viral" post="infectivity and mortality [7–9]. Hemagglutinin (HA), one of the"/>
 <result pre="viral infectivity and mortality [7–9]. Hemagglutinin (HA), one of the" exact="viral" post="surface proteins deeply involved in membrane fusion with the"/>
 <result pre="the fusion peptide hidden within causes membrane fusion to spread" exact="viral" post="RNA to the host cell [10–12]. Disulfide bonds have"/>
 <result pre="HA disulfide bonds and silver nanoparticles (AgNPs) could inhibit IV" exact="infection" post="by cleaving disulfide bonds [16–18]. Therefore, various modifications of"/>
 <result pre="modifications of noble metallic nanoparticles have been tested to mitigate" exact="viral infection," post="i.e., tannic acid-modified silver nanoparticle [19], silver nanoparticle/chitosan composite"/>
 <result pre="gallic acid-functionalized gold nanoparticle [28]. These noble metal-based nanoparticles suppressed" exact="viral infection" post="by blocking viral entry to the host cell. Here,"/>
 <result pre="acid-functionalized gold nanoparticle [28]. These noble metal-based nanoparticles suppressed viral" exact="infection" post="by blocking viral entry to the host cell. Here,"/>
 <result pre="[28]. These noble metal-based nanoparticles suppressed viral infection by blocking" exact="viral" post="entry to the host cell. Here, for an improved"/>
 <result pre="IV by cleaving disulfide bonds, which blocks membrane fusion and" exact="viral" post="entry to the host cell. In the present study,"/>
 <result pre="To visualize this inactivation ability, the amount of post-infection intracellular" exact="viral" post="RNA was measured after nanoparticle treatment. In addition, various"/>
 <result pre="surface proteins and cleaves their disulfide bonds. Inactivated viruses exhibit" exact="lower" post="infectivity to cells Results and discussion Preparation and characterization"/>
 <result pre="synthesized via the seed-mediated growth method to compare whether nanoparticle" exact="morphology" post="could affect inactivation of the virus. AgNP was also"/>
 <result pre="AgNP has been widely studied for its antiviral properties. The" exact="morphology" post="of the synthesized nanoparticles was observed by TEM and"/>
 <result pre="IAV to be induced by cleaving disulfide bonds required for" exact="viral" post="membrane fusion with the host cell. TEM analysis was"/>
 <result pre="and sGNP. On the other hand, AgNP agglomerated on the" exact="viral" post="surface as expected, since the small size of AgNP"/>
 <result pre="of PoGNP-treated H3N2 virus in redispersed precipitate solution was much" exact="lower" post="than that in the supernatant, indicating that H3N2 virus"/>
 <result pre="In addition, PoGNP attracted more H3N2 virus than sGNP at" exact="lower" post="concentration according to the real-time Cq values of precipitated"/>
 <result pre="line: supernatant positive control, black dotted line: precipitate positive control," exact="viral" post="titer: 106 EID50/mL). PoGNP-Prep, precipitate of PoGNP-treated IAV after"/>
 <result pre="nanoparticle suspension for 10 min and 60 min prior to" exact="infection" post="of the MDCK cells. The antiviral effect of the"/>
 <result pre="could interact with HA. AgNP was able to agglomerate on" exact="viral" post="HA and had extensive specific surface area for interaction"/>
 <result pre="higher concentration and it should only be treated at concentrations" exact="lower" post="than 0.1 mg/mL due to toxicity concerns. As observed"/>
 <result pre="than 0.1 mg/mL due to toxicity concerns. As observed by" exact="lower" post="attraction of sGNP to viral HA in the binding"/>
 <result pre="toxicity concerns. As observed by lower attraction of sGNP to" exact="viral" post="HA in the binding efficiency test with centrifugation, sGNP"/>
 <result pre="HA in the binding efficiency test with centrifugation, sGNP exhibited" exact="lower" post="antiviral activity, as expected. Indeed, the inactivation of H1N1"/>
 <result pre="Indeed, the inactivation of H1N1 virus by sGNP was much" exact="lower" post="than that of PoGNP, although sGNP also exhibited affinity"/>
 <result pre="min and b 60 min. Upper line: negative control (N.C.)," exact="lower" post="line: positive control (P.C.). PoGNP porous gold nanoparticle, sGNP"/>
 <result pre="low sequence similarity, so they were considered representative of general" exact="viral" post="treatment [33]. For the 10 min-treated sample, only 0.2"/>
 <result pre="76%, and 56%, respectively. 54% of MDCK cells survived H1N1" exact="infection" post="when treated with 0.1 mg/mL PoGNP for 60 min."/>
 <result pre="[Viral titer: 106 EID50/mL, dotted line: positive control (P.C.)] Intracellular" exact="viral" post="RNA quantification We had inferred the inactivation mechanism of"/>
 <result pre="disulfide bonds in HA would expedite inhibition by PoGNP. The" exact="viral" post="inhibition mechanism of PoGNP was then identified by quantitative"/>
 <result pre="of PoGNP was then identified by quantitative analysis of intracellular" exact="viral" post="RNA from MDCK cells infected with nanoparticle-treated viruses (Fig."/>
 <result pre="curve (Additional file 1: Figure S4). PoGNP-treated H3N2 virus showed" exact="lower" post="intracellular viral RNA levels indicating that the amount of"/>
 <result pre="file 1: Figure S4). PoGNP-treated H3N2 virus showed lower intracellular" exact="viral" post="RNA levels indicating that the amount of IAV in"/>
 <result pre="reduced in the nanoparticle-treated samples. Also, the amount of intracellular" exact="viral" post="RNA was clearly influenced by the exposure time. The"/>
 <result pre="influenced by the exposure time. The gene content level of" exact="viral" post="RNA in the host cells was higher for viruses"/>
 <result pre="viruses treated for 10 min compared with 60 min. Intracellular" exact="viral" post="RNA quantification data corresponded well with the MDCK cell"/>
 <result pre="10 min. Furthermore, the result also confirmed that PoGNP blocked" exact="viral infection" post="by inhibiting viral entry. Fig. 6 EID of intracellular"/>
 <result pre="min. Furthermore, the result also confirmed that PoGNP blocked viral" exact="infection" post="by inhibiting viral entry. Fig. 6 EID of intracellular"/>
 <result pre="result also confirmed that PoGNP blocked viral infection by inhibiting" exact="viral" post="entry. Fig. 6 EID of intracellular viral RNA derived"/>
 <result pre="infection by inhibiting viral entry. Fig. 6 EID of intracellular" exact="viral" post="RNA derived from real-time RT-PCR data, infected after PoGNP"/>
 <result pre="porous gold nanoparticle Demonstrating the importance of disulfide bond in" exact="viral infection" post="We determined that viral infection was suppressed by obstructing"/>
 <result pre="gold nanoparticle Demonstrating the importance of disulfide bond in viral" exact="infection" post="We determined that viral infection was suppressed by obstructing"/>
 <result pre="importance of disulfide bond in viral infection We determined that" exact="viral infection" post="was suppressed by obstructing viral attachment, therefore we further"/>
 <result pre="of disulfide bond in viral infection We determined that viral" exact="infection" post="was suppressed by obstructing viral attachment, therefore we further"/>
 <result pre="infection We determined that viral infection was suppressed by obstructing" exact="viral" post="attachment, therefore we further experimented to prove that the"/>
 <result pre="that the disulfide bonds in HA have important role in" exact="viral infection." post="To support the hypothesis, 5,5′-dithiobis(2-nitrobenzoic acid) (DTNB) reduction assay"/>
 <result pre="was considered as a valid method for proving relationship between" exact="viral" post="disulfide bond reduction and its attenuated infectivity. As described"/>
 <result pre="S5). On the other hand, 0.01 M TCEP-treated samples displayed" exact="lower" post="cell viability compared to other TCEP-treated samples because of"/>
 <result pre="that the cleavage of disulfide bond before membrane fusion reduce" exact="viral" post="infectivity toward MDCK cells. Likewise, as the viral infectivity"/>
 <result pre="fusion reduce viral infectivity toward MDCK cells. Likewise, as the" exact="viral" post="infectivity of PoGNP-reacted influenza virus was suppressed to the"/>
 <result pre="with non-porous gold and silver nanoparticles in this study. Nanoparticle" exact="morphology" post="and interaction with IAV was observed by TEM analysis"/>
 <result pre="proven by coprecipitation during centrifugation. Precipitation of PoGNP-treated IAVs showed" exact="lower" post="real-time Cq values, indicating that more viruses precipitated with"/>
 <result pre="in the supernatant. Furthermore, PoGNP showed more effective inhibition of" exact="viral infection" post="compared with the non-porous sGNP and AgNP because of"/>
 <result pre="the supernatant. Furthermore, PoGNP showed more effective inhibition of viral" exact="infection" post="compared with the non-porous sGNP and AgNP because of"/>
 <result pre="because of its extensive surface area. We suggested that the" exact="viral" post="inhibition mechanism was due to blocking of viral attachment"/>
 <result pre="that the viral inhibition mechanism was due to blocking of" exact="viral" post="attachment associated with membrane fusion, which ensued from the"/>
 <result pre="have considerable spike proteins on the surface, such as human" exact="immunodeficiency" post="virus or coronavirus, by cleaving disulfide bonds in their"/>
 <result pre="Service (Seoul, Korea). The RNeasy® mini kit and the QIAamp®" exact="viral" post="RNA mini kit were purchased from QIAGEN (Hilden, Germany)."/>
 <result pre="assay kit (Daeil Lab Service). Twenty-four hours prior to the" exact="infection" post="experiment, 2.0 × 105 of Madin-Darby canine kidney (MDCK) cells were"/>
 <result pre="190 Microplate Reader (Molecular Devices, San Jose, USA). For intracellular" exact="viral" post="RNA quantification, a 24 h MDCK cell incubation period"/>
 <result pre="Real-time RT-PCR A/canine/Korea/GCVP01/2007(H3N2) virus was serially diluted tenfold (108.25–102.25 EID50/mL)." exact="Viral" post="genomic RNA from each dilution was extracted using the"/>
 <result pre="genomic RNA from each dilution was extracted using the QIAamp®" exact="viral" post="RNA mini kit (QIAGEN), according to the manufacturer’s instructions."/>
 <result pre="reverse transcription-polymerase chain reaction (RT-PCR) was employed to quantify the" exact="viral" post="load in the samples using the QuantiTect Probe RT-PCR"/>
 <result pre="generated with EID values and copy numbers. The amount of" exact="viral" post="RNA in nanoparticle-treated samples (in logEID50/mL) was calculated from"/>
 <result pre="derived by real-time RT-PCR. Figure S5. MDCK cell viability after" exact="infection" post="with TECP-treated H3N2 virus. Upper line: negative control (N.C.),"/>
 <result pre="infection with TECP-treated H3N2 virus. Upper line: negative control (N.C.)," exact="lower" post="line: positive control (P.C.). (viral titer: 106 EID50/mL). Publisher's"/>
 <result pre="authors declare no competing financial interest. References References 1.MahonyJBDetection of" exact="respiratory" post="viruses by molecular methodsClin Microbiol Rev20082171674710.1128/CMR.00037-0718854489 2.ThompsonWWShayDKWeintraubEBrammerLBridgesCBCoxNJFukudaKInfluenza-associated hospitalizations in"/>
 <result pre="a plea for rational useClin Infect Dis2009481254125610.1086/59898919323631 6.collab: Centers for" exact="Disease" post="C, PreventionUpdate: influenza activity–United StatesMorb Mortal Wkly Rep20085713291332 7.ThompsonCIBarclayWSZambonMCChanges"/>
 <result pre="for rapid detection of highly pathogenic influenza virus via a" exact="viral" post="fusion and cell entry mechanismAdv Funct Mater201828180096010.1002/adfm.201800960 13.FontanaJStevenACInfluenza virus-mediated"/>
 <result pre="a determinant of influenza pathogenicity and the origin of the" exact="labile" post="conformationCell19989540941710.1016/S0092-8674(00)81771-79814710 16.MehrbodPMotamedNTabatabaianMSoleimaniERAminiEShahidiMKheiriMTIn vitro antiviral effect of &quot;Nanosilver&quot; on influenza"/>
 <result pre="&quot;Nanosilver&quot; on influenza virusDaru2009178893 17.XiangDZhengYDuanWLiXYinJShigdarSO’ConnorMLMarappanMZhaoXMiaoYet al.Inhibition of A/Human/Hubei/3/2005 (H3N2) influenza" exact="virus infection" post="by silver nanoparticles in vitro and in vivoInt J"/>
 <result pre="on influenza virusDaru2009178893 17.XiangDZhengYDuanWLiXYinJShigdarSO’ConnorMLMarappanMZhaoXMiaoYet al.Inhibition of A/Human/Hubei/3/2005 (H3N2) influenza virus" exact="infection" post="by silver nanoparticles in vitro and in vivoInt J"/>
 <result pre="Nanobiotechnol20053610.1186/1477-3155-3-6 19.OrlowskiPTomaszewskaEGniadekMBaskaPNowakowskaJSokolowskaJNowakZDontenMCelichowskiGGrobelnyJKrzyzowskaMTannic acid modified silver nanoparticles show antiviral activity in" exact="herpes" post="simplex virus type 2 infectionPLoS ONE20149e10411310.1371/journal.pone.010411325117537 20.MoriYOnoTMiyahiraYNguyenVQMatsuiTIshiharaMAntiviral activity of"/>
 <result pre="modified silver nanoparticles show antiviral activity in herpes simplex virus" exact="type 2" post="infectionPLoS ONE20149e10411310.1371/journal.pone.010411325117537 20.MoriYOnoTMiyahiraYNguyenVQMatsuiTIshiharaMAntiviral activity of silver nanoparticle/chitosan composites against"/>
 <result pre="Lett201389310.1186/1556-276X-8-9323421446 21.YangXXLiCMHuangCZCurcumin modified silver nanoparticles for highly efficient inhibition of" exact="respiratory" post="syncytial virus infectionNanoscale201683040304810.1039/C5NR07918G26781043 22.LaraHHAyala-NunezNVIxtepan-TurrentLRodriguez-PadillaCMode of antiviral action of silver"/>
 <result pre="receptor specificity using glycan-functionalized gold nanoparticlesACS Nano201484600460710.1021/nn500248524724848 25.PappISiebenCLudwigKRoskampMBottcherCSchlechtSHerrmannAHaagRInhibition of influenza" exact="virus infection" post="by multivalent sialic-acid-functionalized gold nanoparticlesSmall201062900290610.1002/smll.20100134921104827 26.BowmanMCBallardTEAckersonCJFeldheimDLMargolisDMMelanderCInhibition of HIV fusion"/>
 <result pre="specificity using glycan-functionalized gold nanoparticlesACS Nano201484600460710.1021/nn500248524724848 25.PappISiebenCLudwigKRoskampMBottcherCSchlechtSHerrmannAHaagRInhibition of influenza virus" exact="infection" post="by multivalent sialic-acid-functionalized gold nanoparticlesSmall201062900290610.1002/smll.20100134921104827 26.BowmanMCBallardTEAckersonCJFeldheimDLMargolisDMMelanderCInhibition of HIV fusion"/>
 <result pre="gold nanoparticlesMedchemcomm2011242142310.1039/c0md00229a 28.HaiderADasSOjhaDChattopadhyayDMukherjeeAHighly monodispersed gold nanoparticles synthesis and inhibition of" exact="herpes" post="simplex virus infectionsMater Sci Eng C-Mater Biol Appl20188941342110.1016/j.msec.2018.04.00529752114 29.BangDLeeTChoiJParkYKimEHuhYMHaamSA"/>
 <result pre="robust, high-yield synthetic methodologyRSC Adv20166135541356110.1039/C5RA24772A 31.TaylorARSharpDGMcLeanIWJrBeardDBeardJWDingleJHFellerAEPurification and character of the" exact="swine influenza" post="virusScience19439858758910.1126/science.98.2557.58717835869 32.AroraDJTremblayPBourgaultRBoileauSConcentration and purification of influenza virus from allantoic"/>
</results>
